Skip to main content
. 2020 Oct 25;14(12):3211–3233. doi: 10.1002/1878-0261.12819

Fig. 4.

Fig. 4

Depletion of LINC01578 repressed colon cancer cell viability and mobility. (A) LINC01578 expression in LoVo cells infected with shRNAs targeted to LINC01578. (B) Cell viability of LINC01578‐depleted and control LoVo cells was determined by Glo cell viability assay. (C) Cell proliferation of LINC01578‐depleted and control LoVo cells was determined by EdU assays. Scale bars, 100 µm. (D) Cell migration of LINC01578‐depleted and control LoVo cells was determined by transwell migration assays. Scale bars, 100 µm. (E) Cell invasion of LINC01578‐depleted and control LoVo cells was determined by transwell invasion assays. Scale bars, 100 µm. Data are shown as mean ± SD based on three independent experiments. **P < 0.01, ***P < 0.001, ****P < 0.0001 by one‐way ANOVA followed by Dunnett's multiple comparisons test.